Shanghai Haohai Biological Technology Co. Ltd Net Asset Quality Index
Shanghai Haohai Biological Technology Co. Ltd net asset quality index. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Net Asset Quality Index of 83.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €6.72 Billion minus total liabilities of €1.12 Billion yields net assets of €5.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 5HB total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Net asset quality index of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. This chart shows how Shanghai Haohai Biological Technology Co. Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 83.4%, representing net assets of €5.60 Billion against total assets of €6.72 Billion EUR. Check Shanghai Haohai Biological Technology Co PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Shanghai Haohai Biological Technology Co. Ltd Net Asset Quality Index by Year (2016–2025)
Shanghai Haohai Biological Technology Co. Ltd net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Shanghai Haohai Biological Technology Co worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.4% | €5.60 Billion | €6.72 Billion | €1.12 Billion | ▲ +0.3 pp |
| 2024 | 83.1% | €5.92 Billion | €7.12 Billion | €1.20 Billion | ▼ -1.6 pp |
| 2023 | 84.7% | €6.02 Billion | €7.11 Billion | €1.09 Billion | ▼ -1.0 pp |
| 2022 | 85.6% | €5.90 Billion | €6.89 Billion | €990.02 Million | ▼ -1.6 pp |
| 2021 | 87.2% | €6.06 Billion | €6.95 Billion | €890.07 Million | ▼ -3.8 pp |
| 2020 | 91.0% | €5.73 Billion | €6.30 Billion | €564.46 Million | ▼ -0.9 pp |
| 2019 | 91.9% | €5.65 Billion | €6.15 Billion | €498.52 Million | ▲ +5.4 pp |
| 2018 | 86.5% | €3.84 Billion | €4.44 Billion | €600.90 Million | ▲ +3.8 pp |
| 2017 | 82.6% | €3.37 Billion | €4.08 Billion | €708.59 Million | ▲ +1.8 pp |
| 2016 | 80.8% | €2.99 Billion | €3.69 Billion | €707.55 Million | — |